October 3, 2020 Comments Off on New patent expiration for Astrazeneca Ab drug QTERN Posted in: Uncategorized
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are twelve patents…
The post New patent expiration for Astrazeneca Ab drug QTERN appeared first on…
October 3, 2020 Comments Off on New patent expiration for Astrazeneca Ab drug FARXIGA Posted in: Uncategorized
Annual Drug Patent Expirations for FARXIGA Farxiga is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from three suppliers. There are eighteen patents…
The post New patent expiration for Astrazeneca Ab drug FARXIGA appeare…
